Abstract
Utilizing a pharmacophore hypothesis, previously described γ-secretase inhibiting HTS hits were evolved into novel tricyclic sulfonamide–pyrazoles, with high in vitro potency, good brain penetration, low metabolic stability, and high clearance.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have